Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products
Sponsor: Dawn Gile (District 33)Committee: FinanceSubject: Health - InsuranceStatus: Unfavorable Report by Finance; Withdrawn (as of Nov 13, 2024)
What this bill does
Official synopsis
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal Food and Drug Administration for the complete or partial reversal of an opioid overdose without imposing a copayment or coinsurance requirement that exceeds $10 per package.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (0)
MGA witness listNo witness list on file because no hearing has been scheduled.